These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17886562)

  • 1. Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy.
    Dinca EB; Sarkaria JN; Schroeder MA; Carlson BL; Voicu R; Gupta N; Berger MS; James CD
    J Neurosurg; 2007 Sep; 107(3):610-6. PubMed ID: 17886562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human brainstem glioma xenograft model enabled for bioluminescence imaging.
    Hashizume R; Ozawa T; Dinca EB; Banerjee A; Prados MD; James CD; Gupta N
    J Neurooncol; 2010 Jan; 96(2):151-9. PubMed ID: 19585223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
    Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
    J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
    Hashizume R; Gupta N; Berger MS; Banerjee A; Prados MD; Ayers-Ringler J; James CD; VandenBerg SR
    Neuro Oncol; 2010 Apr; 12(4):366-76. PubMed ID: 20308314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme.
    Lee DY; Chunta JL; Park SS; Huang J; Martinez AA; Grills IS; Krueger SA; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):978-85. PubMed ID: 23845846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.
    Toren A; Pismenyuk T; Yalon M; Freedman S; Simon AJ; Fisher T; Moshe I; Reichardt JK; Constantini S; Mardor Y; Last D; Guez D; Daniels D; Assoulin M; Mehrian-Shai R
    Oncotarget; 2016 Nov; 7(46):74860-74871. PubMed ID: 27556862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.
    Hunn MK; Bauer E; Wood CE; Gasser O; Dzhelali M; Ancelet LR; Mester B; Sharples KJ; Findlay MP; Hamilton DA; Hermans IF
    J Neurooncol; 2015 Jan; 121(2):319-29. PubMed ID: 25366363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
    Tentori L; Leonetti C; Scarsella M; D'Amati G; Vergati M; Portarena I; Xu W; Kalish V; Zupi G; Zhang J; Graziani G
    Clin Cancer Res; 2003 Nov; 9(14):5370-9. PubMed ID: 14614022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noscapine inhibits tumor growth in TMZ-resistant gliomas.
    Jhaveri N; Cho H; Torres S; Wang W; Schönthal AH; Petasis NA; Louie SG; Hofman FM; Chen TC
    Cancer Lett; 2011 Dec; 312(2):245-52. PubMed ID: 21925789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cetuximab efficacy by bioluminescence monitoring of intracranial glioblastoma xenograft in mouse.
    Yang SH; Hong YK; Jeun SS; Kim IS; Hong JT; Sung JH; Son BC; Lee SW; Kim MC; Lee KS
    J Neurooncol; 2009 Oct; 95(1):23-28. PubMed ID: 19381443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
    Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
    Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DMC is not better than TMZ on intracranial anti-glioma effects.
    Shi L; Sun G
    J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma - three case reports - .
    Sakamoto N; Ishikawa E; Yamamoto T; Satomi K; Nakai K; Sato M; Enomoto T; Morishita Y; Takano S; Ohno T; Tsuboi K; Matsumura A
    Neurol Med Chir (Tokyo); 2011; 51(4):319-25. PubMed ID: 21515959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.
    Ashizawa T; Akiyama Y; Miyata H; Iizuka A; Komiyama M; Kume A; Omiya M; Sugino T; Asai A; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
    Int J Oncol; 2014 Jul; 45(1):411-8. PubMed ID: 24820265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery.
    Hadjipanayis CG; Fellows-Mayle W; Deluca NA
    Mol Ther; 2008 Nov; 16(11):1783-8. PubMed ID: 18728637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage temozolomide for prior temozolomide responders.
    Franceschi E; Omuro AM; Lassman AB; Demopoulos A; Nolan C; Abrey LE
    Cancer; 2005 Dec; 104(11):2473-6. PubMed ID: 16270316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial AAV-IFN-β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model.
    GuhaSarkar D; Neiswender J; Su Q; Gao G; Sena-Esteves M
    Mol Oncol; 2017 Feb; 11(2):180-193. PubMed ID: 28098415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
    Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
    Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.